After-Hours Stock Movers 06/16: Adobe Falls on Lower Guidance; U.S. Steel Rises on Higher Guidance (more...)

June 16, 2022 6:01 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

After-Hours Stock Movers:

Rhythm Pharmaceuticals (NASDAQ: RYTM) 14% LOWER; Confirmed the FDA has approved the Company’s supplemental New Drug Application (sNDA) for IMCIVREE® (setmelanotide), a melanocortin-4 receptor (MC4R) agonist, for patients with Bardet-Biedl syndrome (BBS). Also, the FDA issued a complete response letter for the sNDA for setmelanotide in Alström syndrome.

Global Cord Blood Corporation (NYSE: CO) 11% HIGHER; announce that Cellenkos, Inc. recently announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application to initiate a Phase 1b, open-label study of CK0804 as an add on therapy to ruxolitinib in patients with myelofibrosis who experience a suboptimal response to ruxolitinib.

United States Steel Corporation (NYSE: X) 6% HIGHER; adjusted EBITDA expected to be approximately $1.6 billion, representing a new all-time best Q2 performance. Adjusted EPS is expected to range from $3.83 to $3.88, versus the consensus of $3.20.

Adobe Systems (NASDAQ: ADBE) 3% LOWER; reported Q2 EPS of $3.35, $0.04 better than the analyst estimate of $3.31. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.34 billion. Adobe Systems sees Q3 2022 EPS of $3.33, versus the consensus of $3.40. Adobe Systems sees Q3 2022 revenue of $4.43 billion, versus the consensus of $4.51 billion. Adobe Systems sees FY2022 EPS of $13.50, versus the consensus of $13.66. Adobe Systems sees FY2022 revenue of $17.65 billion, versus the consensus of $17.85 billion

LAVA Therapeutics N.V. (Nasdaq: LVTX) 3% HIGHER; hosted a clinical update call focused on encouraging initial Phase 1/2a clinical data for LAVA-051 in patients with chronic lymphocytic leukemia (CLL) and multiple myeloma (MM) patients following poster presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held June 3-7, 2022, and the European Hematology Association (EHA) 2022 Congress, held June 9-12, 2022.

Targa Resources Corp. (NYSE: TRGP) 3% HIGHER; Agreed to acquire Lucid Energy Delaware, LLC from Riverstone Holdings LLC and Goldman Sachs Asset Management for $3.55 billion in cash.

Bausch Health Companies Inc. (NYSE: BHC) 2% HIGHER; Suspending IPO of Solta Medical.

Oasis Petroleum Inc. (NASDAQ: OAS) 1% HIGHER; announced today that its Board of Directors has, subject to certain conditions, declared a special dividend of $15.00 per share of Oasis common stock in connection with the Whiting Petroleum merger.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Goldman Sachs, After-Hours Movers, Definitive Agreement, IPO, FDA